In our biomarker-defined subpopulation, we observed a 0.27 effect size on the EMACC cognitive scale after only 6 months (2). For directional context, this magnitude compares favorably to the 18-month ...
INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO: ...
A new study by Google suggests that advanced reasoning models achieve high performance by simulating multi-agent-like debates involving diverse perspectives, personality traits, and domain expertise.
Live Science on MSN
Can AI detect cognitive decline better than a doctor? New study reveals surprising accuracy
Designed to assist rather than replace doctors, a new autonomous tool scans clinical notes to highlight patients who may need ...
A new artificial intelligence model is being used to screen clinical notes for indications of potential cognitive impairment.
Creativity is more than just a spark. New brain scan studies reveal the complicated interplay between multiple brain systems.
The agent acquires a vocabulary of neuro-symbolic concepts for objects, relations, and actions, represented through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results